NCT06253897View on ClinicalTrials.gov

A Study to Understand Participant's Experiences in Gastro-enteropancreatic Neuroendocrine Tumors (GEP-NETs) and Acromegaly

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

May 29, 2024

Primary Completion Date

December 6, 2024

Study Completion Date

December 6, 2024

Conditions
Gastro-enteropancreatic Neuroendocrine TumorAcromegaly
Trial Locations (1)

46225

Pearl IRB, Indianapolis

Sponsors

Lead Sponsor

Ipsen
All Listed Sponsors
lead

Ipsen

INDUSTRY